ACCELERON PHARMA INC's ticker is XLRN and the CUSIP is 00434H108. A total of 85 filers reported holding ACCELERON PHARMA INC in Q3 2014. The put-call ratio across all filers is 0.95 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2017 | $1,929,000 | +156.5% | 51,678 | +108.9% | 0.01% | +166.7% |
| Q2 2017 | $752,000 | +24.9% | 24,737 | +8.8% | 0.00% | +50.0% |
| Q1 2017 | $602,000 | +14.7% | 22,737 | +10.5% | 0.00% | 0.0% |
| Q4 2016 | $525,000 | -32.7% | 20,569 | -4.6% | 0.00% | -33.3% |
| Q3 2016 | $780,000 | -11.6% | 21,551 | -17.0% | 0.00% | -25.0% |
| Q2 2016 | $882,000 | +40.0% | 25,951 | +8.7% | 0.00% | +33.3% |
| Q1 2016 | $630,000 | -9.4% | 23,874 | +67.5% | 0.00% | 0.0% |
| Q4 2015 | $695,000 | +98.6% | 14,253 | +1.5% | 0.00% | +50.0% |
| Q3 2015 | $350,000 | -36.9% | 14,045 | -19.9% | 0.00% | 0.0% |
| Q2 2015 | $555,000 | +20.9% | 17,545 | +45.6% | 0.00% | 0.0% |
| Q1 2015 | $459,000 | -5.7% | 12,050 | -3.6% | 0.00% | 0.0% |
| Q4 2014 | $487,000 | +27.2% | 12,503 | -1.2% | 0.00% | 0.0% |
| Q3 2014 | $383,000 | -10.7% | 12,656 | +0.3% | 0.00% | 0.0% |
| Q2 2014 | $429,000 | +127.0% | 12,616 | +130.4% | 0.00% | +100.0% |
| Q1 2014 | $189,000 | -2.6% | 5,476 | +12.0% | 0.00% | 0.0% |
| Q4 2013 | $194,000 | – | 4,888 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Darwin Global Management, Ltd. | 938,490 | $120,070,000 | 33.50% |
| Foresite Capital Management III, LLC | 108,630 | $13,898,000 | 16.15% |
| Octagon Capital Advisors LP | 112,363 | $14,376,000 | 4.98% |
| Artal Group S.A. | 1,400,000 | $179,116,000 | 3.84% |
| Avoro Capital Advisors LLC | 1,550,000 | $198,307,000 | 3.42% |
| Affinity Asset Advisors, LLC | 45,000 | $5,757,000 | 3.05% |
| NWI MANAGEMENT LP | 200,000 | $25,588,000 | 2.54% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 71,000 | $9,063,000 | 2.48% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,600,000 | $332,644,000 | 2.00% |
| Parkman Healthcare Partners LLC | 52,458 | $6,711,000 | 1.72% |